首页> 外文期刊>Gastroenterology Research >Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients
【24h】

Missed Diagnosis of Liver Cirrhosis Leads to Disparities in Care for Older Patients

机译:肝硬化诊断漏诊导致老年患者护理差异

获取原文
       

摘要

Background: Cirrhosis of the liver is often not recognized until late in the disease state, when patients decompensate or develop hepatocellular carcinoma (HCC). This inquiry considered factors associated with undiagnosed cirrhosis. Methods: Patients with undiagnosed cirrhosis were compared to patients with known diagnosis of cirrhosis, to evaluate the differences between these two groups. The study population is patients with confirmed diagnosis of HCC, stratified into patients with known diagnosis of cirrhosis (n = 36) and patients without the known diagnosis of cirrhosis who have features of cirrhosis (n = 36). Results: There was no significant difference in insurance, gender, race, etiology of liver disease, presence of splenomegaly, model for end stage liver disease (MELD) score, fibrosis-4 index (FIB-4) or aspartate aminotransferase (AST) to platelet ratio index (APRI) scores between groups. However, the strongest predictor of the diagnosis of cirrhosis was age, with older patients being less likely to be diagnosed with cirrhosis (OR: 0.924, P = 0.012). Furthermore, tumor size in patients without known cirrhosis was larger than those diagnosed with cirrhosis (median: 4.9 cm versus 3.5 cm, P = 0.015). Of note, 50% of cases with cirrhosis were undiagnosed. Conclusion: Older age was the most significant predictor of the missed diagnosis of liver cirrhosis. This led to a larger tumor size at diagnosis, which may imply worse prognosis in these patients. Further evaluation of health disparities related to older age and outcomes of older patients with liver cirrhosis should guide the development of guidelines to prevent the missed diagnosis of cirrhosis.
机译:背景:直到疾病晚期,当患者代偿失调或发展为肝细胞癌(HCC)时,才通常不认识到肝硬化。该询问考虑了与未确诊的肝硬化相关的因素。方法:将未诊断为肝硬化的患者与已知诊断为肝硬化的患者进行比较,以评估两组之间的差异。研究人群为确诊为HCC的患者,分为具有已知肝硬化诊断的患者(n = 36)和没有已知肝硬化诊断且具有肝硬化特征的患者(n = 36)。结果:在保险,性别,种族,肝病病因,脾肿大的存在,终末期肝病模型(MELD)评分,纤维化4指数(FIB-4)或天冬氨酸转氨酶(AST)方面无显着差异。两组之间的血小板比率指数(APRI)得分。然而,肝硬化诊断的最强预测因子是年龄,老年患者被诊断为肝硬化的可能性较小(OR:0.924,P = 0.012)。此外,未发现肝硬化的患者的肿瘤大小大于被诊断为肝硬化的患者的肿瘤大小(中位数:4.9 cm对3.5 cm,P = 0.015)。值得注意的是,有50%的肝硬化病例未被诊断。结论:高龄是肝硬化肝漏诊的最重要预测指标。这导致诊断时肿瘤较大,这可能意味着这些患者的预后较差。进一步评估与老年人和老年肝硬化患者的结局相关的健康差异,应指导指南的制定,以防止漏诊肝硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号